KLRK1 and neoplasm: The activity of NK cells is reduced in pancreatic cancers, and the decreased expression of NKG2D, NKp30, and NKp46 correlates with tumor progression in pancreatic cancer patients (Figure 2; Peng et al., 2013, 2014).